Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Author: Avi Kapoor | June 27, 2024 08:33am

U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Thursday.

Shares of Levi Strauss & Co. (NYSE:LEVI) fell sharply in today’s pre-market trading after the company reported mixed second-quarter financial results and issued FY24 EPS guidance with its midpoint below estimates.

Levi Strauss reported quarterly earnings of 16 cents per share which beat the analyst consensus estimate of 11 cents by 45.45%. Quarterly sales came in at $1.44 billion, missing the analyst consensus estimate of $1.45 billion.

Levi Strauss shares dipped 16.1% to $19.40 in pre-market trading.

Here are some big stocks recording losses in today's pre-market trading session.

Immutep Limited (NASDAQ:IMMP) shares tumbled 29.6% to $1.9493 in pre-market trading after Baird maintained an Outperform rating on the stock but lowered its price target from $7 to $6.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) fell 20.6% to $6.95 in pre-market trading after the company announced the pricing of a $200 million public offering of 30,769,230 shares at $6.50 per share.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) shares declined 15.4% to $13.25 in pre-market trading after the company reported mixed third-quarter results and lowered 2024 guidance below consensus estimates.
International Paper Company (NYSE:IP) shares slipped 11.5% to $41.05 in pre-market trading after Suzano said it will not pursue a transaction involving the company.
Grifols, S.A. (NASDAQ:GRFS) shares fell 10.8% to $6.21 in pre-market trading.
Hims & Hers Health, Inc. (NYSE:HIMS) fell 11.2% to $19.15 in pre-market trading after gaining over 8% on Tuesday.
Elanco Animal Health Incorporated (NYSE:ELAN) shares declined 6.7% to $16.76 in pre-market trading.
AeroVironment, Inc. (NASDAQ:AVAV) shares fell 6.1% to $181.00 in pre-market trading after the company reported fourth-quarter financial results and issued FY25 EPS guidance below estimates.